טוען...
Impact of Biosimilar Insulins on Clinical Practice: Meeting Report
The availability of biosimilar insulins can potentially lead to lower insulin costs and increased access for patients with diabetes, worldwide. However, clinicians and regulatory agencies have raised several concerns regarding the safety and efficacy of these new medications. The European regulatory...
שמור ב:
| הוצא לאור ב: | J Diabetes Sci Technol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4454104/ https://ncbi.nlm.nih.gov/pubmed/24876554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813518267 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|